Skip to main content
logo
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.75
+0.30 (2.23%)
Jun 26, 2026, 12:24 PM EDT - Market open

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $17.16M in the quarter ending March 31, 2026, with 14.96% growth. This brings the company's revenue in the last twelve months to $69.21M, up 7.37% year-over-year. In the fiscal year ending September 30, 2025, Enanta Pharmaceuticals had annual revenue of $65.32M, down -3.42%.

Revenue (ttm)
$69.21M
Revenue Growth
+7.37%
P/S Ratio
5.65
Revenue / Employee
$576,775
Employees
120
Market Cap
399.83M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202565.32M-2.31M-3.42%
Sep 30, 202467.64M-11.57M-14.61%
Sep 30, 202379.20M-6.96M-8.07%
Sep 30, 202286.16M-10.91M-11.24%
Sep 30, 202197.07M-25.40M-20.74%
Sep 30, 2020122.47M-82.72M-40.31%
Sep 30, 2019205.20M-1.43M-0.69%
Sep 30, 2018206.63M103.81M100.97%
Sep 30, 2017102.81M14.55M16.48%
Sep 30, 201688.27M-72.61M-45.13%
Sep 30, 2015160.88M113.14M236.98%
Sep 30, 201447.74M15.69M48.94%
Sep 30, 201332.05M-9.65M-23.15%
Sep 30, 201241.71M-176.00K-0.42%
Sep 30, 201141.88M19.12M83.99%
Sep 30, 201022.76M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Puma Biotechnology227.18M
Century Therapeutics109.16M
Fennec Pharmaceuticals51.00M
Prelude Therapeutics16.72M
X4 Pharmaceuticals9.01M
Adlai Nortye5.00M
Compass Therapeutics850.00K
Revenue Rankings

ENTA News

More News